tbuckley/cabot-search huggingface dataset:
Targeting and Depletion of Acute Myeloid Leukemia Blasts By MEN1112, a Novel Humanized Defucosylated Monoclonal Antibodies with Specificity for Bst1/CD157 Antigen
Authors: Adriano Venditti, Francesco Buccisano, Luca Maurillo, Maria Ilaria Del Principe, Andrea Coppola, Patrizia Palomba, Anna Aureli, Roberto Arriga, Daniela Bellarosa, Alessandro Bressan, Stefano Manzini, Cecilia Simonelli, Monica Binaschi, Sergio Amadori, Giuseppe Sconocchia
Journal: Blood (2014)
RUNX1 Mutations Cause a Myeloid Differentiation Block Leading to the Formation of a Long Term Expanding CD34+/CD33+/CD45RA+/CD123+ Cell Population
Authors: Myléne Gerritsen, Esther Tijchon, Amit Mandoli, Joost H.A. Martens, Jan Jacob Schuringa, Edo Vellenga
Journal: Blood (2016)
Overexpression of KDM6B, an Epigenetic and Innate Immune Regulator, Results in Hematopoietic Alterations of Mice Including Changes in Hematopoietic Stem Cells
Authors: Yue Wei, Hong Zheng, Yu Jia, Naran Bao, Shan Jiang, Simona Colla, Carlos E Bueso-Ramos, Joseph D Khoury, Zachary S. Bohannan, Guillermo Garcia-Manero
Journal: Blood (2016)
The Predictive Role of Circulating Serum Free Light Chains (sFLC) in HIV-Associated Non Hodgkin's Lymphoma (NHL) and Hodgkin's Disease (HD) and Its Correlation with Effective Combined Antiretroviral Treatment (cART)
Authors: Michele Bibas, Maria Paola Trotta, Patrizia Lorenzini, Alessandro Cozzi-Lepri, M. Borderi, Valerio Tozzi, Massimo Galli, Gioacchino Angarano, M. Montroni, M. Arlotti, G. Carnevale, Nicola Abrescia, Leopoldo Paolo Pucillo, Antonella D'Arminio Monforte, Andrea Antinori
Journal: Blood (2010)
Deregulated Gene Expression Pathways in Myelodysplastic Syndrome Hematopoietic Stem Cells.
Authors: Andrea Pellagatti, Mario Cazzola, Aristoteles Giagounidis, Janet Perry, Luca Malcovati, Matteo G Della Porta, Martin Jädersten, Sally Killick, Amit Verma, Eva Hellström-Lindberg, James S Wainscoat, Jacqueline Boultwood
Journal: Blood (2009)
Suitable reference genes determination for real-time PCR using induced sputum samples
Authors: Catherine Moermans, Esteban Deliege, Dimitri Pirottin, Christophe Poulet, Julien Guiot, Monique Henket, Jane da Silva, Renaud Louis
Journal: European Respiratory Journal (2019)

Induced sputum is a non-invasive method of collecting cells from airways. Gene expression analysis from sputum cells has been used to understand the underlying mechanisms of airway diseases such as asthma or chronic obstructive pulmonary disease (COPD). Suitable reference genes for normalisation of target mRNA levels between sputum samples have not been defined so far. The current study assessed the expression stability of nine common reference genes in sputum samples from 14 healthy volunteers, 12 asthmatics and 12 COPD patients. Using three different algorithms (geNorm, NormFinder and BestKeeper), we identified HPRT1 and GNB2L1 as the most optimal reference genes to use for normalisation of quantitative reverse transcriptase (RT) PCR data from sputum cells. The higher expression stability of HPRT1 and GNB2L1 were confirmed in a validation set of patients including nine healthy controls, five COPD patients and five asthmatic patients. In this group, the RNA extraction and RT-PCR methods differed, which attested that these genes remained the most reliable whatever the method used to extract the RNA, generate complementary DNA or amplify it. Finally, an example of relative quantification of gene expression linked to eosinophils or neutrophils provided more accurate results after normalisation with the reference genes identified as the most stable compared to the least stable and confirmed our findings.
Immune Modulation of Minimal Residual Disease (MRD) in Patients (pts) with Chronic Myelogenous Leukemia (CML) in Early Chronic Phase (CP): A Randomized Trial of Frontline High-Dose (HS) Imatinib Mesylate (IM) with or without Pegylated-Interferon (PEG-IFN) and GM-CSF.
Authors: Alfonso Quintas-Cardama, Hagop M. Kantarjian, Farhad Ravandi, Guillermo Garcia-Manero, Susan O’Brien, Srdan Verstovsek, Charles Asa Koller, Odeal Pate, Jorge Cortes
Journal: Blood (2006)
Results of an Ongoing Phase 2 Study of Brentuximab Vedotin with Rchp As Frontline Therapy in Patients with High-Intermediate/High-Risk Diffuse Large B Cell Lymphoma (DLBCL)
Authors: Lihua E. Budde, Ahmad Halwani, Christopher A. Yasenchak, Charles Michael Farber, John M Burke, Luis E. Fayad, Beata Holkova, Mark Knapp, Kathryn S. Kolibaba, Ranjana H Advani, Stephen M Ansell, Dipti Patel-Donnelly, Habte A. Yimer, Scott E. Smith, Moshe Yair Levy, Mahesh Seetharam, David Belada, Donald Brooks, Edwin C. Kingsley, Leonard M. Klein, Nina Wagner-Johnston, Katherine Ruffner, Nancy L Bartlett
Journal: Blood (2016)
SYK Inhibition Disrupts the Cross-Talk Between B-Cell Activation Factor (BAFF) and B-Cell Receptor (BCR) and Thereby Antagonizes Mcl-1 in Chronic Lymphocytic Leukemia (CLL) B-Cells
Authors: Cody Paiva, Taylor Rowland, Olga Danilova, Bhargava Sreekantham, Stephen E Spurgeon, Alexey V Danilov
Journal: Blood (2016)
Abstract #905: The small molecule Tetradrine (NSC77037), identified in a high-throughput cell-based screen, reverses multidrug resistance in cancer cells
Authors: Zhenfeng Duan, Edwin Choy, Cao Yang, Joseph Schwab, Henry Mankin, Francis Hornicek
Journal: Cancer Research (2009)

Multidrug resistance (MDR) is one of the major factors which contributes to the failure of cancer chemotherapy treatment, and because of MDR, numerous efforts have been made to overcome it in the recent years. To identify novel MDR inhibitors, we developed a 96-well plate high-throughput cell-based screening assay. Using this assay on the National Cancer Institute Diversity Set Library, we identified tetradrine (NSC77037), a small molecular compound that, reverses MDR1 (Pgp) but not MRP or BCRP-mediated MDR in multidrug resistant cell lines derived from human tumors. The ability to reverse MDR is comparable to that of frequently used reversal agents such as verapamil and CsA. Cytotoxic activity of tetradrine was evaluated in vitro using human sarcoma and ovarian, breast, and colon cancer cell lines expressing various levels of Pgp, as well as using a lung cancer cell line expressing MRP and a breast cancer cell line expressing BCRP. From these results, we found that tetradrine itself at concentration >10µM moderately inhibits the proliferation of both sensitive and resistant cells with almost equal activity, but its inhibitory effect is not altered by co-incubation with verapamil, suggesting that tetradrine may not be a substrate of Pgp. Additionally, tetradrine increases the intracellular accumulation of Pgp substrates: Calcein AM, Rhodamine-123, paclitaxel, mitoxantrone, and doxorubicin, by enhancing the uptake and/or decreasing the efflux of these compounds in resistant cells. Finally, we are also able to show that tetradrine directly inhibiting the function of Pgp in a dose-dependent manner. In contrast, tetradrine does not inhibit the total expression level of Pgp. These results indicate that tetradrine is capable of reversing MDR in many cancer cells to chemotherapeutic agents by directly inhibiting the function of Pgp. The ability of tetradrine to restore sensitivity to drug therapy or to prevent resistance could potentially benefit a large number of cancer patients.  Citation Information: In: Proc Am Assoc Cancer Res; 2009 Apr 18-22; Denver, CO. Philadelphia (PA): AACR; 2009. Abstract nr 905.
Minimal Residual Disease Negative Complete Remissions Following Anti-CD22 Chimeric Antigen Receptor (CAR) in Children and Young Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL)
Authors: Nirali N Shah, Maryalice Stetler-Stevenson, Constance M. Yuan, Haneen Shalabi, Bonnie Yates, Cindy Delbrook, Ling Zhang, Daniel W. Lee, David Stroncek, Crystal L. Mackall, Terry J Fry
Journal: Blood (2016)
Next Generation Flow (NGF) Cytometry for Minimal Residual Disease (MRD) Evaluation in Multiple Myeloma (MM) Patients with Sustained Complete Response (CR) after Frontline Therapy: Results of a Prospective Single-Center Analysis
Authors: Evangelos Terpos, Ioannis V. Kostopoulos, Eftathios Kastritis, Ioannis Ntanasis-Stathopoulos, Magdalini Migkou, Alexandra T. Argyriou, Nikolaos Kanellias, Despina Fotiou, Evangelos Eleutherakis-Papaiakovou, Maria Gavriatopoulou, Stavroula Giannouli, Marilyn Spyropoulou-Vlachou, Ourania E. Tsitsilonis, Bruno Paiva, Meletios A. Dimopoulos
Journal: Blood (2017)
Infusion of Unrelated-Donor Partially HLA-Matched Cells Results in Detectable Microchimerism in Patients with Acute Myeloid Leukemia: Early Post-Infusion Reactions Are Common but Self-Limiting
Authors: David Kliman, Emily Blyth, Kenneth Yehson, Vicki Antonenas, Leighton Clancy, John Kwan, Michael Haeusler, David Ritchie, David Gottlieb
Journal: Blood (2016)
Frailty and invasive mechanical ventilation: association with outcomes, extubation failure, and tracheostomy
Authors: Shannon M. Fernando, Daniel I. McIsaac, Bram Rochwerg, Sean M. Bagshaw, John Muscedere, Laveena Munshi, Niall D. Ferguson, Andrew J. E. Seely, Deborah J. Cook, Chintan Dave, Peter Tanuseputro, Kwadwo Kyeremanteng
Journal: Intensive Care Medicine (2019)
Airway Dilation in Bronchiolitis Obliterans After Allogeneic Hematopoietic Stem Cell Transplantation.
Authors: Lee Gazourian, Anna Maria F Coronata, Angela J Rogers, Gerald L Weinhouse, Robert J. Soiffer, Joseph H. Antin, Jerome Ritz, Vincent T Ho, Rebecca M Baron, George R Washko
Journal: Blood (2012)
Allogeneic Stem Cell Transplant in First Complete Remission Overcomes the Poor Prognosis Associated with the FLT-3 Internal Tandem Duplication in Acute Myeloid Leukemia.
Authors: Maryse M. Power, Giovanna Di Sauro, Angela Brooks-Wilson, Thomas J. Nevill, Julye C. Lavoie, Clayton A. Smith, John D. Shepherd, Cindy L. Toze, Heather J. Sutherland, Michael J. Barnett, Yasser A. Abou Mourad, Kevin W. Song, Donna M. Forrest, Steven H. Nantel, Stanley C. Wong, Anna A. Krasnova, Ryan Brinkman, Donna E. Hogge
Journal: Blood (2007)
Elevated Monoclonal Free Light Chains Are a Serum Marker of ABC Type Diffuse Large B-Cell Lymphoma
Authors: Matthew J Maurer, James R Cerhan, Jerry A Katzmann, Ahmet Dogan, Mamta Gupta, William R Macon, Sergei I Syrbu, Brian K Link, Ivana N. Micallef, Thomas E Witzig
Journal: Blood (2011)
Abstract 18132: Utility of Risk Stratification to Predict Early Mortality in Patients with Critical Limb Ischemia
Authors: Atsushi Tosaka, Yoshimitsu Soga, Osamu Iida, Keisuke Hirano, Kenji Suzuki, Nobuyoshi Masakiyo
Journal: Circulation (2012)

Background: Revascularization is the optimal treatment to avoid major amputation for critical limb ischemia (CLI) patients. It has been also reported that the presence of CLI was strongly associate...
Atypical Hemolytic Uremic Syndrome In Japan Characterized By The Inhibitory Antibody-Based Hemolytic Assay and The Gene Analysis
Authors: Yoko Yoshida, Xinping Fan, Yoshifumi Ohyama, Tetsuro Kokubo, Masanori Matsumoto, Hideo Yagi, Hiroko Shirotani-Ikejima, Toshiyuki Miyata, Yoshihiro Fujimura
Journal: Blood (2013)
Does adherence to inhaled corticosteroids predict asthma-related outcomes over time? A cohort study
Authors: Alexandra L. Dima, Eric van Ganse, Gertraud Stadler, Marijn de Bruin
Journal: European Respiratory Journal (2019)

Inhaled corticosteroids (ICS) adherence is important for asthma management. Current evidence on the impact of ICS adherence on outcomes is mostly based on correlational analyses of between-person data. Although it is widely acknowledged that asthma outcomes fluctuate over time, evidence on predictors of within-person change is scarce. We aimed to quantify these fluctuations and the longitudinal relationships between ICS adherence and outcomes at both between- and within-person levels. A prospective cohort of persistent asthma patients in France and the UK (n=847, age 6−40 years) provided 3756 reports over up to 2 years via computer-assisted telephone interviews and text messages on ICS adherence, asthma control, reliever medication use and exacerbations. We examined adherence−outcome relationships via longitudinal models, controlling for confounders, including severity. Considerable within-person variability was found for exacerbations (91%), asthma control (59%) and reliever use (52%); 431 (11.5%) reports signalled exacerbations and 2046 (54.5%) poor control. At between-person level, patients with higher average adherence were more likely to report asthma control (OR 1.25, 95% CI 1.06−1.47), but not asthma exacerbations (OR 0.99, 95% CI 0.87−1.12) or lower reliever use (b −0.0004, 95% CI −0.089−0.088). At within-person level, higher-than-usual adherence was associated with higher concomitant reliever use (b 0.092, 95% CI 0.053−0.131) and lower subsequent reliever use (b −0.047, 95% CI −0.005− −0.088); it was unrelated to asthma control (OR 0.93, 95% CI 0.84−1.02) or exacerbations (OR 1.04, 95% CI 0.94−1.16). Patients maintaining high ICS adherence over time have better asthma control. Temporarily increasing ICS adherence tends to be simultaneous to higher reliever use and reduces reliever use later on. Causes of within-person variation in outcomes require more investigation.
Survival of Patients with Rare Plasma Cell or Lymphoplasmacytoid Malignancies in Germany and the United States in the Early 21st Century
Authors: Dianne Pulte, Janick Weberpals, Lina Jansen, Alexander Katalinic, Alice Nennecke, Holleczek Bernd, Ressing Meike, Luttmann Sabine, Hermann Brenner
Journal: Blood (2016)
Bronchiolitis Obliterans Syndrome after Hematopoietic Stem Cell Transplantation: A Retrospective Multicenter Survey of the Late Effect Working Party EBMT.
Authors: Mutlu Arat, Gérard Socié, Jacob R. Passweg, Dolores Caballero, Per T. Ljungman, Francesca Bonifazi, Ozlem O. Kumbasar, A.O. Fernandez, D. Broeters, Stefano Guidi, J. Greil, Axel R. Zander, Andre Tichelli, Albert N. Bekassy
Journal: Blood (2006)
Impact of Atorvastatin on Cellular Immunome of Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT)
Authors: Yvonne A Efebera, Susan Geyer, Anissa Bingman, Rhonda Kitzler, Patrick Elder, Leslie A. Andritsos, Samantha M. Jaglowski, Sumithira Vasu, William Blum, Rebecca B. Klisovic, Sam Penza, Kevin Coombes, Craig C Hofmeister, Don Benson, Steven M. Devine, Gerard Lozanski
Journal: Blood (2014)
Treatment of Hodgkin Lymphoma Xenografts with the Novel PI3K δ/γ Inhibitor RP6530 Suppresses M2 Macrophage Polarization and Results in Potent Antitumor and Antiangiogenic Effects
Authors: Silvia Laura Locatelli, Francesca Maria Consonni, Giuseppa Careddu, Simone Serio, Srikant Viswanadha, Swaroop Vakkalanka, Luca Castagna, Armando Santoro, Carmelo Carlo-Stella
Journal: Blood (2016)
Remission Duration ≤ 12 Months for Early Relapsed and Refractory Follicular Lymphoma Is Predictive of Early Failures Post-High Dose Therapy and Autologous Stem Cell Rescue.
Authors: Matthew A Lunning, Jocelyn C Maragulia, Craig H. Moskowitz, Matthew J. Matasar, Hugo Castro-Malaspina, Sergio Giralt, Andrew D. Zelenetz, Craig S. Sauter
Journal: Blood (2012)
CC-122 Dosing on a Novel Intermittent Schedule Mitigates Neutropenia and Maintains Clinical Activity in Subjects with Relapsed or Refractory Diffuse Large B Cell Lymphoma
Authors: Cecilia Carpio, Loïc Ysebaert, Raúl Cordoba, Armando Santoro, José Antonio López-Martín, Juan Manuel Sancho, Carlos Panizo, Mecide Meric Gharibo, Drew W Rasco, Anne-Marie Stoppa, Sylvia Damian, Xin Wei, Patrick Hagner, Kristen Hege, Soraya Carrancio, Anita K. Gandhi, Michael Pourdehnad, Vincent Ribrag
Journal: Blood (2015)
Retrospective Analysis of Hemorrhagic Cystitis After Unrelated Donor Hematopoietic Stem Cell Transplantation In a Chinese Population.
Authors: Jing Jing, Kangni Wu, Yi Luo, Jimin Shi, Yamin Tan, Jingsong He, Weiyan Zheng, Haowen Xiao, Zhen Cai, Maofang Lin, Xiujin Ye, He Huang
Journal: Blood (2010)
Rapid Detection of SAP Deficiency in Cytotoxic Lymphocytes from Patients with X-Linked Lymphoproliferative Disease and Their Family Members.
Authors: Yasuhiro Tabata, Joyce Villanueva, Susan M. Lee, Kejian Zhang, Hirokazu Kanegane, Toshio Miyawaki, Janos Sumegi, Alexandra H. Filipovich
Journal: Blood (2004)
Sphingosine-1-Phosphate (S1P) Signaling through S1P Receptor 1 (S1PR1) in Macrophage Contributes to Pain in Sickle Cell Disease
Authors: Morayo G. Adebiyi, Yujin Zhang, Kaiqi Sun, Xia Hu, Shusuan Zhao, Hongyu Wu, Jacob Couturier, Dorothy L. Lewis, Edgar T. Walters, Yang Xia
Journal: Blood (2016)
Long Term Efficacy of Rituximab in B-Cell Post Transplantation Lymphoproliferative Disorders (B-PTLD): Update of the Multicenter, Open Label, Phase II Trial (M39037 TRIAL).
Authors: Sylvain Choquet, Raoul Herbrecht, Anne-marie Stoppa, Peter Vandenberghe, Walter Feremans, Franck Morschhauser, Gilles Andre Salles, Arnaud Jaccard, Thierry Lamy, Yves Lebranchu, Philippe Offner, Eric Oksenhendler, Martine Raphael, Veronique Leblond, Noel-Jean Milpied
Journal: Blood (2006)
High Levels of Hematopoietic Progenitors in the Fetal Lung Enable Induction of Immune Tolerance and Co-Transplantation of Epithelial Progenitors for Repair of Lung Injury Across MHC Barriers
Authors: Carmit Hillel Karniel, Chava Rosen, Esther Bachar Lustig, Elias Shezen, Yair Reisner
Journal: Blood (2016)
Single 4.5mg Dose of Rasburicase for Tumor Lysis Syndrome In Adults
Authors: Barbara Yim, Anne Navaleza, Augustin Haidau, Shylendra Sreenivasappa, Mohammed A. Kassem, Bety C. Ciobanu, Tareq Braik, Manila Gaddh, Paul G. Rubinstein, Moushmi Shah, Margaret Telfer, Rose Catchatourian
Journal: Blood (2010)
Placental Growth Factor (PlGF) Enhances TLR/MK2 Dependent TNF Gene Transcription and Dissociates miRNAs Targeting TNF Regulatory Transcripts from the Polysome
Authors: Laura F. Newell, Nicholas Burwick, Christina A Harrington, Kristina Vartanian, Julja Burchard, Shernan G. Holtan, Akiko Shimamura, Grover C. Bagby
Journal: Blood (2016)
Mussel‐Inspired Tough Hydrogel with In Situ Nanohydroxyapatite Mineralization for Osteochondral Defect Repair
Authors: Donglin Gan, Zhixiong Wang, Chaoming Xie, Xiao Wang, Wensi Xing, Xiang Ge, Huipin Yuan, Kefeng Wang, Hui Tan, Xiong Lu
Journal: Advanced Healthcare Materials (2019)

Abstract Repairing osteochondral defects is a considerable challenge because it involves the breakdown of articular cartilage and underlying bone. Traditional hydrogels with a homogenized single‐layer structure cannot fully restore the function of osteochondral cartilage tissue. In this study, a mussel‐inspired hydrogel with a bilayer structure is developed to repair osteochondral defects. The hydrogel is synthesized by simultaneously polymerizing two layers using a one‐pot method. The resulting upper and lower gelatin methacryloyl‐polydopamine hydrogel layers are used as cartilage and subchondral bone repair layers, respectively. Polydopamine‐induced hydroxyapatite in situ mineralization takes place in the lower layer to mimic the structure of subchondral bone. The bilayer hydrogel exhibits good mechanical properties for the synergistic effect of covalent and noncovalent bonds, as well as nanoreinforcement of mineralized hydroxyapatite. To improve the tissue‐inducibility of hydrogels, transforming growth factor β 3 is immobilized in the upper layer to induce cartilage regeneration, while bone morphogenetic protein 2 is immobilized in the lower layer to induce bone regeneration. Bone and cartilage repair performance of the hydrogel is examined by implantation into a full‐thickness cartilage defect of a rabbit knee joint. The bilayer‐structure hydrogel promotes regeneration of osteochondral tissue, thus providing a new option for repair of osteochondral defects.
Spatially Organized Structure of Coronary Thrombus in Acute Myocardial Infarction
Authors: Jan E. Dyr, Tomas Riedel, Jana Stikarova, Jiri Suttnar, Jaroslav Cermak, Roman Kotlin, Martin Hajsl, Petr Tousek, Viktor Kocka, Martin Maly
Journal: Blood (2016)
BRD4 Proteolysis Targeting Chimera (PROTAC) ARV-825, Causes Sustained Degradation of BRD4 and Modulation of Chemokine Receptors, Cell Adhesion and Metabolic Targets in Leukemia Resulting in Profound Anti-Leukemic Effects
Authors: Sujan Piya, Seemana Bhattacharya, Hong Mu, Philip L Lorenzi, Teresa McQueen, Eric Richard Davis, Vivian Ruvolo, Natalia Baran, Yimin Qian, Craig Crews, Hagop M. Kantarjian, Michael Andreeff, Gautam Borthakur
Journal: Blood (2016)
Targeted Intravenous Busulfan and Fludarabine Allogeneic Transplantation Conditioning in Acute Myeloid Leukemia.
Authors: Joseph A. Pidala, Jongphil Kim, Claudio Anasetti, Melissa Alsina, Ernesto Ayala, Teresa Field, Mohamed A Kharfan-Dabaja, Jose L Ochoa, Lia Perez, Janelle Perkins, Marcie Tomblyn, Hugo F. Fernandez
Journal: Blood (2009)
Severe Thalassemia Intermedia Resulting From Coinheritance of IVSI-110 G&gt;A Beta Gene Mutation and Duplication of Alpha-Globin Gene Cluster in Homozygosis.
Authors: Chiara Refaldi, Wilma Barcellini, Elena Cassinerio, Giovanna Graziadei, Maria Domenica Cappellini
Journal: Blood (2009)
Cell atlas of the foetal human heart and implications for autoimmune-mediated congenital heart block
Authors: Hemant Suryawanshi, Robert Clancy, Pavel Morozov, Marc K Halushka, Jill P Buyon, Thomas Tuschl
Journal: Cardiovascular Research (2019)

Investigating human heart development and applying this to deviations resulting in disease is incomplete without molecular characterization of the cell types required for normal functioning. We investigated foetal human heart single-cell transcriptomes from mid-gestational healthy and anti-SSA/Ro associated congenital heart block (CHB) samples.
High Dose Thiotepa, Busulfan, Cyclophosphamide (TBC) and Autologous Hematopoietic Stem Cell Transplantation (ASCT) without Whole Brain Radiotherapy (WBRT) for Primary Central Nervous System Lymphoma (PCNSL).
Authors: Douglas A. Stewart, Peter Forsyth, Ahsan Chaudhry, Oluyemi Jeje, Donald Morris, Lynn Savoie, Chris Brown, James R. Russell
Journal: Blood (2004)
Characterization of Patients with Glanzmann Thrombasthenia and Identification of 17 Novel Mutations
Authors: Kirstin Sandrock-Lang, Johannes Oldenburg, Verena Wiegering, Susan Halimeh, Sentot Santoso, Karin Kurnik, Lars Fischer, Dimitrios Tsakiris, Michael Sigl-Kraetzig, Brigit Brand, Katharina Kraetzer, Niklas Deeg, Eileen Busse, Zieger Barbara
Journal: Blood (2014)
Preferential Acquision of N-Glycosylation Sites in the VDJ Region in Germinal Center B-Cell-Like Difusse Large B-Cell Lymphoma
Authors: Miguel Alcoceba, Elena Sebastián, Ana Balanzategui, Luis Marín, Santiago Montes-Moreno, Teresa Flores, Noemí Puig, M. Eugenia Sarasquete, M. Carmen Chillón, Cristina Jiménez, Rocío Corral, Eva González-Barca, M. Dolores Caballero, Jesús F. San Miguel, Ramón García-Sanz, Marcos González
Journal: Blood (2012)
Differentiation Status Revealed By Shotgun Phosphoproteomics Determines Sensitivity of Primary AML Cells to Kinase Inhibitors
Authors: Pedro Casado, Edmund Wilkes, Marym M Hadi, Vinothini Rajeeve, Farideh Miraki-Moud, Rebecca Pike, Ana Del Rio-Machin, Sameena Iqbal, Jude Fitzgibbon, John Gribben, Pedro R Cutillas
Journal: Blood (2016)
Allogeneic Stem Cell Transplantation As Salvage Therapy for First Relapse after Autografting in Multiple Myeloma Patients
Authors: Evgeny Klyuchnikov, Christine Wolschke, Anita Badbaran, Maximilian Christopeit, Ute-Marie von Pein, Francis A. Ayuk, Nicolaus Kröger
Journal: Blood (2016)
Heightened Susceptibility to Influenza Mortality in Immunodeficient Mice Caused by a T-Cell Specific Defect in SOD2.
Authors: Adam John Case, Jodi L. Mcgill, Stephen C. Sangster, Joshua M. Madsen, Lorraine T. Tygrett, Anna G. Johns, Takamune Takahashi, Takuji Shirasawa, Douglas R. Spitz, David K. Meyerholz, Thomas J Waldschmidt, Kevin L Legge, Frederick E. Domann
Journal: Blood (2009)
Venetoclax Synergizes with Radiation Therapy for Treatment of B-Cell Lymphomas
Authors: Shyril O'Steen, Amelia Waltman, Garrett Booth, Aimee L Kenoyer, Margaret Nartea, Chelsea Mullins, Yukang Lin, Sang Yun Lee, Mark D Hylarides, Johnnie J. Orozco, Damian J. Green, Ajay K. Gopal, Brian G. Till, Oliver W Press
Journal: Blood (2016)